J. B. Chemicals & Pharmaceuticals Limited

NSEI:JBCHEPHARM 株式レポート

時価総額:₹271.5b

J. B. Chemicals & Pharmaceuticals マネジメント

マネジメント 基準チェック /24

J. B. Chemicals & Pharmaceuticalsの CEO はNikhil Chopraで、 Dec2020年に任命され、 の在任期間は 3.92年です。 の年間総報酬は₹ 71.34Mで、 49.2%給与と50.8%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の0.026%を直接所有しており、その価値は₹ 69.90M 。経営陣と取締役会の平均在任期間はそれぞれ1.8年と4.1年です。

主要情報

Nikhil Chopra

最高経営責任者

₹71.3m

報酬総額

CEO給与比率49.2%
CEO在任期間3.9yrs
CEOの所有権0.03%
経営陣の平均在職期間1.8yrs
取締役会の平均在任期間4.1yrs

経営陣の近況

Most Shareholders Will Probably Agree With J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) CEO Compensation

Aug 15
Most Shareholders Will Probably Agree With J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) CEO Compensation

Recent updates

We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt

Nov 27
We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt

J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates

Nov 09
J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates

J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) Business Is Yet to Catch Up With Its Share Price

Sep 24
J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) Business Is Yet to Catch Up With Its Share Price

Most Shareholders Will Probably Agree With J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) CEO Compensation

Aug 15
Most Shareholders Will Probably Agree With J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) CEO Compensation

J. B. Chemicals & Pharmaceuticals Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Aug 11
J. B. Chemicals & Pharmaceuticals Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

These 4 Measures Indicate That J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Using Debt Reasonably Well

Jun 28
These 4 Measures Indicate That J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Using Debt Reasonably Well

J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar

Apr 19
J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar

J. B. Chemicals & Pharmaceuticals Limited Just Missed Earnings - But Analysts Have Updated Their Models

Feb 09
J. B. Chemicals & Pharmaceuticals Limited Just Missed Earnings - But Analysts Have Updated Their Models

J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar

Dec 22
J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar

We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt

Nov 29
We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt

J. B. Chemicals & Pharmaceuticals' (NSE:JBCHEPHARM) Dividend Will Be Increased To ₹9.25

Aug 03
J. B. Chemicals & Pharmaceuticals' (NSE:JBCHEPHARM) Dividend Will Be Increased To ₹9.25

J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Due To Pay A Dividend Of ₹8.50

Feb 11
J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Due To Pay A Dividend Of ₹8.50

Is J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Using Too Much Debt?

Dec 03
Is J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Using Too Much Debt?

A Look At The Intrinsic Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)

Sep 21
A Look At The Intrinsic Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)

J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Seems To Use Debt Quite Sensibly

Aug 03
J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Seems To Use Debt Quite Sensibly

Estimating The Fair Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)

Jun 15
Estimating The Fair Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)

Does J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Have A Healthy Balance Sheet?

Mar 29
Does J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Have A Healthy Balance Sheet?

J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Has Re-Affirmed Its Dividend Of ₹8.50

Feb 16
J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Has Re-Affirmed Its Dividend Of ₹8.50

CEO報酬分析

J. B. Chemicals & Pharmaceuticals の収益と比較して、Nikhil Chopra の報酬はどのように変化したか?
日付総報酬給与会社業績
Sep 30 2024n/an/a

₹6b

Jun 30 2024n/an/a

₹6b

Mar 31 2024₹71m₹35m

₹6b

Dec 31 2023n/an/a

₹5b

Sep 30 2023n/an/a

₹5b

Jun 30 2023n/an/a

₹4b

Mar 31 2023₹65m₹37m

₹4b

Dec 31 2022n/an/a

₹4b

Sep 30 2022n/an/a

₹4b

Jun 30 2022n/an/a

₹4b

Mar 31 2022₹59m₹18m

₹4b

Dec 31 2021n/an/a

₹4b

Sep 30 2021n/an/a

₹5b

Jun 30 2021n/an/a

₹4b

Mar 31 2021₹32m₹7m

₹4b

報酬と市場: Nikhilの 総報酬 ($USD 846.14K ) は、 Indian市場 ($USD 610.84K ) の同規模の企業の平均を上回っています。

報酬と収益: Nikhilの報酬は、過去 1 年間の会社の業績と一致しています。


CEO(最高経営責任者

Nikhil Chopra (51 yo)

3.9yrs

在職期間

₹71,338,000

報酬

Mr. Nikhil Ashokkumar Chopra serves as Chief Executive Officer and Whole-Time Director at J. B. Chemicals & Pharmaceuticals Limited since December 23, 2020 and has been its Director since May 10, 2020. He...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Nikhil Chopra
CEO & Whole-Time Director3.9yrs₹71.34m0.026%
₹ 69.9m
Suresh Amin
Assistant Vice President – Human Resourceno data₹10.48m0.0025%
₹ 6.7m
Narayan Saraf
Chief Financial Officerless than a year₹12.74mデータなし
Kunal Khanna
President of Operationsno data₹28.44mデータなし
Bhagwat Deora
Vice President of Finance & Accountsno data₹9.48mデータなし
Suresh Bhise
Vice President of Information & Technology9.8yrs₹10.70mデータなし
Sridhar Bharadwaj
Vice President of HR & Administration8.2yrs₹13.80m0.00084%
₹ 2.3m
Himanshu Ranvah
Vice President of Legal1.8yrs₹11.49mデータなし
Pradeep Singh
President of Global Businessno data₹42.09m0.012%
₹ 31.5m
Parmeshwar Bang
Executive Vice President of Operations of Daman1.3yrs₹17.24m0.0048%
₹ 13.1m
Bhushan Sachdev
Executive Vice President of Supply Chain Operationsno data₹19.54m0.0084%
₹ 22.7m
Jason D'Souza
Executive Vice Presidentless than a year₹18.12m0.0032%
₹ 8.7m

1.8yrs

平均在職期間

51yo

平均年齢

経験豊富な経営陣: JBCHEPHARMの経営陣は 経験豊富 とはみなされません ( 1.8年の平均在職年数)。これは新しいチームを示唆しています。


取締役

名称ポジション在職期間報酬所有権
Nikhil Chopra
CEO & Whole-Time Director4.1yrs₹71.34m0.026%
₹ 69.9m
Shadrack Mapetla
Chairman of Biotech Laboratories (Pty ) Ltdno dataデータなしデータなし
Arun Duggal
Non-Executive Independent Chairmanless than a yearデータなしデータなし
Padmini Kaicker
Non-Executive & Independent Director4.3yrs₹7.50mデータなし
Prashant Kumar
Non-Executive Director4.3yrsデータなしデータなし
Akshay Tanna
Non-Executive & Non-Independent Directorless than a yearデータなしデータなし
Gaurav Trehan
Non-Executive Director3.8yrsデータなしデータなし
Sumit Bose
Non-Executive & Independent Director4.3yrs₹7.50mデータなし

4.1yrs

平均在職期間

64.5yo

平均年齢

経験豊富なボード: JBCHEPHARMの 取締役会経験豊富 であると考えられます ( 4.1年の平均在任期間)。